Bioreactors Market Size to Surpass USD 24.24 billion by 2030, exhibiting a 12.6% CAGR by 2030

Bioreactors_industry
๐๐๐๐จ๐ซ๐๐ข๐ง๐ ๐ญ๐จ ๐ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ฉ๐ฎ๐๐ฅ๐ข๐ฌ๐ก๐๐ ๐๐ฒ ๐๐ฑ๐๐๐ญ๐ข๐ญ๐ฎ๐๐ ๐๐จ๐ง๐ฌ๐ฎ๐ฅ๐ญ๐๐ง๐๐ฒ, -GE Healthcare, Merck KGaA
LUTON, BEDFORDSHIRE, UNITED KINGDOM, August 26, 2024 /EINPresswire.com/ -- latest recently released a research report titled global Bioreactors Market insight, forecast to 2030, which assesses various factors influencing its trajectory. The report presents a high-quality, accurate, and comprehensive research study to provide players with valuable insights for making strategic business decisions. The research analysts have conducted an in-depth segmental analysis of the global Bioreactors market based on type, application, and geography. The vendor landscape is also illuminated to inform readers about potential changes in market competition. Detailed company profiling of the top players in this market is included as part of the competitive analysis. Players can leverage the value chain analysis and porterโs five forces analysis offered in the report to strengthen their position in the Bioreactors market.
๐๐ก๐ ๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐๐ญ ๐๐.๐% ๐๐๐๐ ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐. ๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก ๐๐๐จ๐ฏ๐ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐ ๐๐ซ๐จ๐ฆ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐.
๐๐๐ญ ๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ @:
https://exactitudeconsultancy.com/reports/29878/bioreactors-market/#request-a-sample
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ:
GE Healthcare, Merck KGaA, Eppendorf AG, Sartorius AG, Thermo Fisher Scientific Inc., BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Getinge, Infos HT, and others.
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ:
In 2022, Merck announced the acquisition of Lonza's MAST platform, an automated aseptic bioreactor sampling system. These platforms assist customers in optimising data during bioprocessing. This acquisition will assist the company in expanding its market presence.
In December 2023, Sartorius Stedim Biotech announced a โฌ40 million expansion of its single-use bioreactor production facility in Germany to meet increasing demand. This strategic move indicates their confidence in the biopharma sector and single-use bioreactor technologies. It suggests anticipation of continued growth in demand for biopharmaceuticals, potentially driven by factors like personalized medicine and vaccine development.
๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ
In addition, there is a greater need for clinical-stage bioreactors due to the global expansion of research and development efforts aimed at developing preventive vaccines. For example, Serum Institute of India Pvt. Ltd. (SIIPL) has received CSR bioreactors from ABEC to produce the COVID-19 vaccine. Throughout the course of the projection period, the market will continue to expand significantly due to the growing utilization of bioreactors in several production facilities.
๐๐๐๐ ๐ญ๐ก๐ ๐๐ฎ๐ฅ๐ฅ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:
https://exactitudeconsultancy.com/reports/29878/bioreactors-market/
๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ
The market for bioreactors has been expanding significantly because to the rising need for biopharmaceuticals, such as cell treatments, vaccines, and monoclonal antibodies. The increased incidence of chronic illnesses and the continued advancement of individualized care are mostly to blame for this increase. The market has also been significantly shaped by technological developments like single-use bioreactors, which provide adaptable and affordable options for both small- and large-scale production. Further growth is anticipated to be fueled by the biopharmaceutical industry's expansion into emerging countries as well as higher spending in research and development.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ: ๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ ๐๐ฒ๐ฉ๐, ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐ก๐จ๐ฎ๐ฌ๐๐ง๐ ๐๐ง๐ข๐ญ๐ฌ)
Single Use
Reusable
๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐๐ฅ๐ฅ, ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐ก๐จ๐ฎ๐ฌ๐๐ง๐ ๐๐ง๐ข๐ญ๐ฌ)
Mammalian Cells
Bacterial Cells
Yeast Cells
Others
๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐จ๐ฅ๐๐๐ฎ๐ฅ๐, ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐ก๐จ๐ฎ๐ฌ๐๐ง๐ ๐๐ง๐ข๐ญ๐ฌ)
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Stem Cells
Gene Therapy
Others
๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐ฌ๐๐ ๐ , ๐๐๐๐-๐๐๐๐, (๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐ก๐จ๐ฎ๐ฌ๐๐ง๐ ๐๐ง๐ข๐ญ๐ฌ)
Developmental, Preclinical & Clinical
Commercial Production
Bioreactors Market By End Use, 2020-2030, (USD Billion, Thousand Units)
Research And Development (R&D) Organizations
Biopharmaceutical (Biopharma) Manufacturers
Contract Manufacturing Organizations (CMOS)
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐๐ข๐จ๐ซ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ข๐ฏ๐ข๐๐๐ ๐ข๐ง๐ญ๐จ ๐๐จ๐ฎ๐ซ ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ: ๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐, ๐๐ฎ๐ซ๐จ๐ฉ๐, ๐๐ฌ๐ข๐ ๐๐๐๐ข๐๐ข๐, ๐๐ง๐ ๐๐๐๐๐
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐
The market for bioreactors is dominated by North America. The market for bioreactors in the area is primarily driven by the existence of significant industry players who consistently fund pharmaceutical and vaccine R&D. Regional governments are also actively encouraging and funding the manufacturing of biologics. Over the past 20 years, the biopharmaceutical and biotechnology sectors in North America have experienced tremendous growth. Gene therapy, monoclonal antibodies, and stem cell research have all resulted in a sharp rise in the quantity of bioreactors in use. The need for treatments and bioreactors has increased due to the region's rising incidence of infectious and chronic illnesses.
๐๐ฌ๐ข๐-๐๐๐๐ข๐๐ข๐
The market for bioreactors in Asia-Pacific is expanding significantly because to the increased spending on bioreactors by governments and biopharmaceutical companies. For example, the Indian Department of Science and the Department of Biotechnology offer numerous research and startup funds, including the BIG grant and NIDHI Prayas grant. Global leaders like Agilent, Merck, Thermo Fischer, and Eppendorf also make significant investments in the region because of the region's advantageous legislation and the accessibility of inexpensive labor in developing nations like China and India.
๐๐ฎ๐ซ๐จ๐ฉ๐
Over the projection period, Europe is anticipated to have significant growth. In Europe, the use of next-generation bioreactors has grown significantly, particularly in the pharmaceutical industry. The region's abundance of biotechnology companies offers lucrative prospects for producers of bioprocessing machinery. The region's potential bioreactor demand will be consolidated by increased efforts to discover and produce huge quantities of novel medicines, monoclonal antibodies, vaccines, and stem cells. The European Commission (EC) has suggested a new patient-centered pharmaceutical strategy for its member states in order to guarantee the quality and safety of medications. In a similar vein, the European Commission is pushing for funding to coordinate the creation, advancement, and manufacturing of innovative antibiotics as part of the recently established EU Health Emergency Response Authority.
๐๐๐๐ ๐๐ฎ๐ซ ๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Healthcare Middleware Market- https://exactitudeconsultancy.com/reports/11098/healthcare-middleware-market/
The global healthcare middleware market is expected to grow at 11% CAGR from 2022 to 2029. It is expected to reach above USD 5.65 billion by 2029 from USD 2.21 billion in 2020.
Cartilage Repair or Cartilage Regeneration Market- https://exactitudeconsultancy.com/reports/28377/cartilage-repair-or-cartilage-regeneration-market/
The Cartilage Repair or Cartilage Regeneration market is expected to grow at 13.20 % CAGR from 2022 to 2029. It is expected to reach above USD 2609.66 Million by 2029 from USD 855 Million in 2020.
Sleep Apnea Oral Appliances Market - https://exactitudeconsultancy.com/reports/23934/sleep-apnea-oral-appliances-market/
The global Sleep Apnea Oral Appliances market is expected to grow at a 15.3% CAGR from 2022 to 2029, from USD 260.19 million in 2020.
EHealthย ย Market - https://exactitudeconsultancy.com/reports/7863/ehealth-market/
The global EHealth market size is USD 69.69 Billion in 2020 and is expected to grow till USD 455.60 Billion by 2029, at a Compounded annual growth rate (CAGR) of 23.45%.
Medical Plastics Marketย - https://exactitudeconsultancy.com/reports/16341/medical-plastics-market/
ย The global medical plastics market is expected to grow at 6% CAGR from 2020 to 2029. It is expected to reach above USD 35.54 billion by 2029 from USD 23.32 billion in 2020.
Contrast Media Injectors Market- https://exactitudeconsultancy.com/reports/7755/contrast-media-injectors-market/
The global contrast media injectors market is expected to grow at 7.45% CAGR from 2022 to 2029. It is expected to reach above 2.43 USD billion by 2029 from 1.30 USD billion in 2020.
Biodegradable Plastics Market - https://exactitudeconsultancy.com/reports/6714/biodegradable-plastics-market/
Biodegradable plastics market size was valued at USD 5.9 billion in 2020 and is projected to reach USD 43.95 billion by 2029, growing at a CAGR of 25% from 2022 to 2029.
ย Bio Plasticizer Market- https://exactitudeconsultancy.com/reports/23920/bio-plasticizer-market/
The global bio plasticizer market is expected to grow at 4.6% CAGR from 2020 to 2029. It is expected to reach above USD 2.07 Billion by 2029 from USD 1.38 Billion in 2020.
Contrast Media/Contrast Agent Market- https://exactitudeconsultancy.com/reports/7789/contrast-media-contrast-agent-market/
The global contrast media/contrast agent market is expected to grow at 3.65% CAGR from 2022 to 2029. It is expected to reach above 6.45 USD billion by 2029 from 4.79 USD billion in 2020.
Sterilization Equipment Market-https://exactitudeconsultancy.com/reports/15161/sterilization-equipment-market/
The Sterilization Equipment market is expected to grow at 8.5 % CAGR from 2022 to 2029. It is expected to reach above USD 22.09 billion by 2029 from USD 8.9 billion in 2020.
๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง:
๐๐๐ญ ๐ฆ๐จ๐ซ๐ :https://exactitudeconsultancy.com/primary-research/
https://bulletin.exactitudeconsultancy.com/
๐๐๐ง ๐ ๐ฆ๐จ๐๐ข๐๐ฒ ๐ญ๐ก๐ ๐ฌ๐๐จ๐ฉ๐ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ง๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ ๐ข๐ญ ๐ญ๐จ ๐ฌ๐ฎ๐ข๐ญ ๐ฆ๐ฒ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐๐ฆ๐๐ง๐ญ๐ฌ?
Yes. Customized requirements of multi-dimensional, deep-level, and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus winning them sufficient time and space for market competition.
- 20% customization.
- 5 Countries can be added as per your choice.
- 5 Companies can add as per your choice.
- Free customization for up to 40 hours.
- After-sales support for 1 year from the date of delivery.
๐๐ก๐๐ง๐ค๐ฌ ๐๐จ๐ซ ๐ซ๐๐๐๐ข๐ง๐ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ญ๐ข๐๐ฅ๐โฆ!! ๐ฒ๐จ๐ฎ ๐๐๐ง ๐๐ฅ๐ฌ๐จ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ญ๐จ ๐ ๐๐ญ ๐ฌ๐๐ฅ๐๐๐ญ ๐๐ก๐๐ฉ๐ญ๐๐ซ๐ฌ ๐จ๐ซ ๐ซ๐๐ ๐ข๐จ๐ง-๐ฐ๐ข๐ฌ๐ ๐๐จ๐ฏ๐๐ซ๐๐ ๐ ๐ฐ๐ข๐ญ๐ก ๐ซ๐๐ ๐ข๐จ๐ง๐ฌ ๐ฌ๐ฎ๐๐ก ๐๐ฌ ๐๐ฌ๐ข๐, ๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐, ๐๐ง๐ ๐๐ฎ๐ซ๐จ๐ฉ๐.
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
Contact Us:
Irfan T
Exactitude Consultancy
+1 704-266-3234
email us here
Visit us on social media:
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.